Mechelen, Belgium; November 3, 2025, 22:01 CET; Galapagos NV (Euronext & NASDAQ: GLPG) today announced that it will present new and updated data for CAR T-cell therapy candidate, GLPG51011, at the ...
Tech Xplore on MSN
Software developers show less constructive skepticism when using AI assistants than when working with human colleagues
When writing program code, software developers often work in pairs—a practice that reduces errors and encourages knowledge sharing. Increasingly, AI assistants are now being used for this role.
Females have a higher odds of chronic rhinosinusitis (CRS) without nasal polyps than men. HealthDay News — Females have a higher odds of chronic rhinosinusitis (CRS) without nasal polyps than men, ...
Session Name: 631. Myeloproliferative Syndromes and Chronic Myeloid Leukemia: Basic and Translational: Precision targeting in MPN Session Date and Time: December 6, 2025; 9:30 AM – 11:00 AM ...
March Biosciences (March Bio), an emerging clinical stage biotechnology company committed to combating challenging cancers and other diseases, today announced that interim clinical data from its ...
CREATE Medicines, Inc. (formerly Myeloid Therapeutics), a clinical-stage biotech pioneering in vivo multi-immune programming, today announced that clinical results from its Phase 1 MYE Symphony trial ...
When your data is organized and labeled, users can ask questions of it, gaining insights without having to manually search ...
Amgen to present new data from cardiovascular portfolio, including late-breaking results from phase 3 VESALIUS-CV trial of Repatha at AHA scientific sessions: Thousand Oaks, Calif ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback